DBV Technologies | DBVT - Trade Creditors


DBV Technologies reported $39.5M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 44.57M 32.32M Jun/2026
Alnylam Pharmaceuticals USD 108.02M 18.61M Jun/2026
Amarin USD 18.8M 29.36M Jun/2026
BioCryst Pharmaceuticals USD 11.46M 501K Jun/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
DBV Technologies USD 39.5M 1.44M Mar/2026
Galectin Therapeutics USD 3.7M 99K Jun/2024
Halozyme Therapeutics USD 14.1M 6.8M Mar/2026
Incyte USD 1.39B 1.16B Jun/2026
Insmed USD 74.55M 1.18M Jun/2026
Ionis Pharmaceuticals USD 47.7M 21.67M Jun/2026
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
PTC Therapeutics USD 40.45M 14.96M Jun/2026
Sarepta Therapeutics USD 50.98M 19.39M Jun/2026
Ultragenyx Pharmaceutical USD 39M 3M Jun/2026
United Therapeutics USD 497.8M 500K Jun/2026